Ligand validation:6RF0

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6RF0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RF0_OLC_B_304	12%	36%	0.278	0.901	1.31	1.3	1	2	1	0	48%	0.48
6RF0_OLC_D_303	10%	39%	0.312	0.907	1.35	1.09	1	1	2	0	48%	0.48
6RF0_OLC_E_302	8%	33%	0.287	0.862	1.44	1.32	1	2	0	0	48%	0.48
6RF0_OLC_A_302	6%	31%	0.295	0.832	1.48	1.38	1	2	0	0	48%	0.48
6RF0_OLC_C_303	6%	39%	0.364	0.888	1.37	1.1	1	2	0	0	52%	0.52
6YC1_OLC_D_308	48%	44%	0.122	0.943	1.23	0.98	1	2	0	0	56%	0.56
6RF3_OLC_D_307	43%	42%	0.123	0.924	1.24	1.05	1	2	0	0	56%	0.56
6YC3_OLC_D_307	40%	45%	0.149	0.937	1.21	0.95	1	2	0	0	56%	0.56
6RF4_OLC_B_301	39%	50%	0.16	0.886	1	0.92	1	1	4	0	88%	0.88
6RFC_OLC_A_328	30%	56%	0.176	0.839	0.91	0.78	1	1	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.